BRSF Stock Overview
Brain Scientific Inc., a medtech company, provides neurology and motion products in the United States and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Brain Scientific Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.75 |
52 Week High | US$11.05 |
52 Week Low | US$0.75 |
Beta | -0.33 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | -92.40% |
3 Year Change | -99.20% |
5 Year Change | n/a |
Change since IPO | -99.70% |
Recent News & Updates
Recent updates
Shareholder Returns
BRSF | US Medical Equipment | US Market | |
---|---|---|---|
7D | 0% | 1.8% | 3.3% |
1Y | -92.4% | 0.6% | 25.8% |
Return vs Industry: BRSF underperformed the US Medical Equipment industry which returned -1.8% over the past year.
Return vs Market: BRSF underperformed the US Market which returned 15.2% over the past year.
Price Volatility
BRSF volatility | |
---|---|
BRSF Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 7.8% |
Market Average Movement | 6.1% |
10% most volatile stocks in US Market | 16.7% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BRSF has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine BRSF's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2013 | 11 | Hassan Kotob | www.brainscientific.com |
Brain Scientific Inc., a medtech company, provides neurology and motion products in the United States and internationally. It offers NeuroCap, a disposable soft layered cap with an integrated electrode circuit that is designed to address existing problems of conventional electroencephalography (EEG) systems; NeuroEEG amplifier and desktop software used to store and analyze data captured from the NeuroCap; and piezoelectric motors. The company is also developing NeuroHub, which allow users to access patient and clinical data to evaluate patient conditions remotely.
Brain Scientific Inc. Fundamentals Summary
BRSF fundamental statistics | |
---|---|
Market cap | US$931.99k |
Earnings (TTM) | -US$12.34m |
Revenue (TTM) | US$214.56k |
4.3x
P/S Ratio-0.1x
P/E RatioIs BRSF overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BRSF income statement (TTM) | |
---|---|
Revenue | US$214.56k |
Cost of Revenue | US$160.24k |
Gross Profit | US$54.33k |
Other Expenses | US$12.40m |
Earnings | -US$12.34m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | -9.93 |
Gross Margin | 25.32% |
Net Profit Margin | -5,753.00% |
Debt/Equity Ratio | 64.2% |
How did BRSF perform over the long term?
See historical performance and comparison